<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31721001</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1166</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of molecular neuroscience : MN</Title><ISOAbbreviation>J Mol Neurosci</ISOAbbreviation></Journal><ArticleTitle>Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS.</ArticleTitle><Pagination><StartPage>643</StartPage><EndPage>657</EndPage><MedlinePgn>643-657</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12031-019-01411-y</ELocationID><Abstract><AbstractText>The neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) share some common molecular deficits including disruption of protein homeostasis leading to disease-specific protein aggregation. While insoluble protein aggregates are the defining pathological confirmation of diagnosis, patient stratification based on early molecular etiologies may identify distinct subgroups within a clinical diagnosis that would respond differently in therapeutic development programs. We are developing targeted multiple reaction monitoring (MRM) mass spectrometry methods to rigorously quantify CSF proteins from known disease genes involved in lysosomal, ubiquitin-proteasomal, and autophagy pathways. Analysis of CSF from 21 PD, 21 ALS, and 25 control patients, rigorously matched for gender, age, and age of sample, revealed significant changes in peptide levels between PD, ALS, and control. In patients with PD, levels of two peptides for chromogranin B (CHGB, secretogranin 1) were significantly reduced. In CSF of patients with ALS, levels of two peptides from ubiquitin carboxy-terminal hydrolase like protein 1 (UCHL1) and one peptide each for glycoprotein non-metastatic melanoma protein B (GPNMB) and cathepsin D (CTSD) were all increased. Analysis of patients with ALS separated into two groups based on length of survival after CSF sampling revealed that the increases in GPNMB and UCHL1 were specific for short-lived ALS patients. While analysis of additional cohorts is required to validate these candidate biomarkers, this study suggests methods for stratification of ALS patients for clinical trials and identifies targets for drug efficacy measurements during therapeutic development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Shaochun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, Neurosciences, Ume&#xe5; University, Building 10, NUS, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wuolikainen</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Junfang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Chemistry, Ume&#xe5; University, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;hman</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, Neurosciences, Ume&#xe5; University, Building 10, NUS, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wingsle</LastName><ForeName>Gunnar</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moritz</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Forest Genetics and Plant Physiology, Swedish University of Agricultural Sciences, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, Neurosciences, Ume&#xe5; University, Building 10, NUS, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forsgren</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Science, Neurosciences, Ume&#xe5; University, Building 10, NUS, Ume&#xe5;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trupp</LastName><ForeName>Miles</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8095-053X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Science, Neurosciences, Ume&#xe5; University, Building 10, NUS, Ume&#xe5;, Sweden. miles.trupp@umu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>927/16</GrantID><Agency>Parkinsonfonden</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Mol Neurosci</MedlineTA><NlmUniqueID>9002991</NlmUniqueID><ISSNLinking>0895-8696</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C503042">GPNMB protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C482860">UCHL1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D043222">Ubiquitin Thiolesterase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013058" MajorTopicYN="N">Mass Spectrometry</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025202" MajorTopicYN="N">Molecular Diagnostic Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043222" MajorTopicYN="N">Ubiquitin Thiolesterase</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">CSF biomarker</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Protein homeostasis</Keyword><Keyword MajorTopicYN="N">Proteomics</Keyword></KeywordList><CoiStatement>The authors declare they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31721001</ArticleId><ArticleId IdType="pmc">PMC6858390</ArticleId><ArticleId IdType="doi">10.1007/s12031-019-01411-y</ArticleId><ArticleId IdType="pii">10.1007/s12031-019-01411-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anderson DJ. Determination of the lower limit of detection. Clin Chem. 1989;35:2152&#x2013;2153.</Citation><ArticleIdList><ArticleId IdType="pubmed">2619804</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakkar N, Boehringer A, Bowser R. Use of biomarkers in ALS drug development and clinical trials. Brain Res. 2015;1607:94&#x2013;107. doi: 10.1016/j.brainres.2014.10.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.10.031</ArticleId><ArticleId IdType="pmc">PMC4809521</ArticleId><ArticleId IdType="pubmed">25452025</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop P, Rocca D, Henley JM. Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction. Biochem J. 2016;473:2453&#x2013;2462. doi: 10.1042/BCJ20160082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20160082</ArticleId><ArticleId IdType="pmc">PMC4980807</ArticleId><ArticleId IdType="pubmed">27515257</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridel Claire, van Wieringen Wessel N., Zetterberg Henrik, Tijms Betty M., Teunissen Charlotte E., Alvarez-Cerme&#xf1;o Jos&#xe9; C., Andreasson Ulf, Axelsson Markus, B&#xe4;ckstr&#xf6;m David C., Bartos Ales, Bjerke Maria, Blennow Kaj, Boxer Adam, Brundin Lou, Burman Joachim, Christensen Tove, Fialov&#xe1; Lenk&#xe1;, Forsgren Lars, Frederiksen Jette L., Gissl&#xe9;n Magnus, Gray Elizabeth, Gunnarsson Martin, Hall Sara, Hansson Oskar, Herbert Megan K., Jakobsson Joel, Jessen-Krut Jan, Janelidze Shorena, Johannsson Gudmundur, Jonsson Michael, Kappos Ludwig, Khademi Mohsen, Khalil Michael, Kuhle Jens, Land&#xe9;n Mikael, Leinonen Ville, Logroscino Giancarlo, Lu Ching-Hua, Lycke Jan, Magdalinou Nadia K., Malaspina Andrea, Mattsson Niklas, Meeter Lieke H., Mehta Sanjay R., Modvig Signe, Olsson Tomas, Paterson Ross W., P&#xe9;rez-Santiago Josu&#xe9;, Piehl Fredrik, Pijnenburg Yolande A. L., Pyykk&#xf6; Okko T., Ragnarsson Oskar, Rojas Julio C., Romme Christensen Jeppe, Sandberg Linda, Scherling Carole S., Schott Jonathan M., Sellebjerg Finn T., Simone Isabella L., Skillb&#xe4;ck Tobias, Stilund Morten, Sundstr&#xf6;m Peter, Svenningsson Anders, Tortelli Rosanna, Tortorella Carla, Trentini Alessandro, Troiano Maria, Turner Martin R., van Swieten John C., V&#xe5;gberg Mattias, Verbeek Marcel M., Villar Luisa M., Visser Pieter Jelle, Wallin Anders, Weiss Andreas, Wikkels&#xf8; Carsten, Wild Edward J. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology. JAMA Neurology. 2019;76(9):1035. doi: 10.1001/jamaneurol.2019.1534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.1534</ArticleId><ArticleId IdType="pmc">PMC6580449</ArticleId><ArticleId IdType="pubmed">31206160</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi YS, Hou S, Choe LH, Lee KH. Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates. J Chromatogr B Anal Technol Biomed Life Sci. 2013;930:129&#x2013;135. doi: 10.1016/j.jchromb.2013.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchromb.2013.05.003</ArticleId><ArticleId IdType="pmc">PMC3710693</ArticleId><ArticleId IdType="pubmed">23735279</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu R, Andreasson U, Li S, Podust VN, Mattsson N, Anckarsater R, Anckarsater H, Rosengren L, Holmberg B, Blennow K, Wikkelso C, Ruetschi U, Zetterberg H. Proteomic profiling of cerebrospinal fluid in parkinsonian disorders. Parkinsonism Relat Disord. 2010;16:545&#x2013;549. doi: 10.1016/j.parkreldis.2010.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2010.06.011</ArticleId><ArticleId IdType="pubmed">20620095</ArticleId></ArticleIdList></Reference><Reference><Citation>Davison EJ, Pennington K, Hung CC, Peng J, Rafiq R, Ostareck-Lederer A, Ostareck DH, Ardley HC, Banks RE, Robinson PA. Proteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function. Proteomics. 2009;9:4284&#x2013;4297. doi: 10.1002/pmic.200900126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200900126</ArticleId><ArticleId IdType="pubmed">19725078</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Vera J, Morales YG, Hernandez-Fernaud JR, Camacho M, Montesinos MS, Calegari F, Huttner WB, Borges R, Machado JD. Chromogranin B gene ablation reduces the catecholamine cargo and decelerates exocytosis in chromaffin secretory vesicles. J Neurosci. 2010;30:950&#x2013;957. doi: 10.1523/JNEUROSCI.2894-09.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2894-09.2010</ArticleId><ArticleId IdType="pmc">PMC6633114</ArticleId><ArticleId IdType="pubmed">20089903</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos MCT, Scheller D, Schulte C, Mesa IR, Colman P, Bujac SR, Bell R, Berteau C, Perez LT, Lachmann I, Berg D, Maetzler W, Nogueira da Costa A. Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosis. PLoS One. 2018;13:e0206536. doi: 10.1371/journal.pone.0206536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0206536</ArticleId><ArticleId IdType="pmc">PMC6211693</ArticleId><ArticleId IdType="pubmed">30383831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebhardt HA, Root A, Sander C, Aebersold R. Applications of targeted proteomics in systems biology and translational medicine. Proteomics. 2015;15:3193&#x2013;3208. doi: 10.1002/pmic.201500004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201500004</ArticleId><ArticleId IdType="pmc">PMC4758406</ArticleId><ArticleId IdType="pubmed">26097198</ArticleId></ArticleIdList></Reference><Reference><Citation>EFNS task force on diagnosis and management of ALS, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol 19:360&#x2013;375. 10.1111/j.1468-1331.2011.03501.x</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson L, Trygg J, Wold S. CV-ANOVA for significance testing of PLS and OPLS (R) models. J Chemom. 2008;22:594&#x2013;600. doi: 10.1002/cem.1187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cem.1187</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanara P, Wong PY, Husted KH, Liu S, Liu VM, Kohlstaedt LA, Riiff T, Protasio JC, Boban D, Killion S, Killian M, Epling L, Sinclair E, Peterson J, Price RW, Cabin DE, Nussbaum RL, Bruhmann J, Brandt R, Christine CW, Aminoff MJ, Hellerstein MK. Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J Clin Invest. 2012;122:3159&#x2013;3169. doi: 10.1172/JCI64575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI64575</ArticleId><ArticleId IdType="pmc">PMC3428100</ArticleId><ArticleId IdType="pubmed">22922254</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, Jacobsson J, Rosquist R, Marklund SL, Brannstrom T. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS One. 2010;5:e11552. doi: 10.1371/journal.pone.0011552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011552</ArticleId><ArticleId IdType="pmc">PMC2904380</ArticleId><ArticleId IdType="pubmed">20644736</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Andersen PM, Marklund SL, Brannstrom T. Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2011;121:623&#x2013;634. doi: 10.1007/s00401-011-0805-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0805-3</ArticleId><ArticleId IdType="pmc">PMC3085063</ArticleId><ArticleId IdType="pubmed">21287393</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg K, Graffmo K, Pakkenberg B, Weber M, Nielsen M, Marklund S, Brannstrom T, Andersen PM. Misfolded SOD1 inclusions in patients with mutations in C9orf72 and other ALS/FTD-associated genes. J Neurol Neurosurg Psychiatry. 2019;90:861&#x2013;869. doi: 10.1136/jnnp-2018-319386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319386</ArticleId><ArticleId IdType="pmc">PMC6691870</ArticleId><ArticleId IdType="pubmed">30992335</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsgren L, Almay BG, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand. 1983;68:20&#x2013;29. doi: 10.1111/j.1600-0404.1983.tb04810.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1983.tb04810.x</ArticleId><ArticleId IdType="pubmed">6604389</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabriel TL, Tol MJ, Ottenhof R, van Roomen C, Aten J, Claessen N, Hooibrink B, de Weijer B, Serlie MJ, Argmann C, van Elsenburg L, Aerts JM, van Eijk M. Lysosomal stress in obese adipose tissue macrophages contributes to MITF-dependent Gpnmb induction. Diabetes. 2014;63:3310&#x2013;3323. doi: 10.2337/db13-1720.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-1720</ArticleId><ArticleId IdType="pubmed">24789918</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam M, Jara JH, Sekerkova G, Yasvoina MV, Martina M, Ozdinler PH. Absence of alsin function leads to corticospinal motor neuron vulnerability via novel disease mechanisms. Hum Mol Genet. 2016;25:1074&#x2013;1087. doi: 10.1093/hmg/ddv631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv631</ArticleId><ArticleId IdType="pmc">PMC4764190</ArticleId><ArticleId IdType="pubmed">26755825</ArticleId></ArticleIdList></Reference><Reference><Citation>Genc B, Lagrimas AK, Kuru P, Hess R, Tu MW, Menichella DM, Miller RJ, Paller AS, Ozdinler PH. Visualization of sensory neurons and their projections in an upper motor neuron reporter line. PLoS One. 2015;10:e0132815. doi: 10.1371/journal.pone.0132815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132815</ArticleId><ArticleId IdType="pmc">PMC4519325</ArticleId><ArticleId IdType="pubmed">26222784</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson SB, Kasarskis EJ, Hu N, Pulst SM, Mendiondo MS, Matthews DE, Mitsumoto H, Tandan R, Simmons Z, Kryscio RJ, Bromberg MB. Relationship of creatine kinase to body composition, disease state, and longevity in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:473&#x2013;477. doi: 10.3109/21678421.2015.1062516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1062516</ArticleId><ArticleId IdType="pmc">PMC5595062</ArticleId><ArticleId IdType="pubmed">26312548</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Z, Gao L, Guo J, Lu Y, Zang D. bFGF in the CSF and serum of sALS patients. Acta Neurol Scand. 2015;132:171&#x2013;178. doi: 10.1111/ane.12381.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12381</ArticleId><ArticleId IdType="pubmed">25631037</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros-Louis F, Andersen PM, Dupre N, Urushitani M, Dion P, Souchon F, D'Amour M, Camu W, Meininger V, Bouchard JP, Rouleau GA, Julien JP. Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2009;106:21777&#x2013;21782. doi: 10.1073/pnas.0902174106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0902174106</ArticleId><ArticleId IdType="pmc">PMC2799865</ArticleId><ArticleId IdType="pubmed">20007371</ArticleId></ArticleIdList></Reference><Reference><Citation>Heywood WE, Galimberti D, Bliss E, Sirka E, Paterson RW, Magdalinou NK, Carecchio M, Reid E, Heslegrave A, Fenoglio C, Scarpini E, Schott JM, Fox NC, Hardy J, Bahtia K, Heales S, Sebire NJ, Zetterburg H, Mills K. Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Mol Neurodegener. 2015;10:64. doi: 10.1186/s13024-015-0059-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0059-y</ArticleId><ArticleId IdType="pmc">PMC4666172</ArticleId><ArticleId IdType="pubmed">26627638</ArticleId></ArticleIdList></Reference><Reference><Citation>World Medical Association (2013) Declaration of Helsinki, www.wma.net</Citation></Reference><Reference><Citation>Hsu SH, Lai MC, Er TK, Yang SN, Hung CH, Tsai HH, Lin YC, Chang JG, Lo YC, Jong YJ. Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) regulates the level of SMN expression through ubiquitination in primary spinal muscular atrophy fibroblasts. Clin Chim Acta. 2010;411:1920&#x2013;1928. doi: 10.1016/j.cca.2010.07.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2010.07.035</ArticleId><ArticleId IdType="pubmed">20713032</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwaki H, Blauwendraat C, Leonard HL, Liu G, Maple-Grodem J, Corvol JC, Pihlstrom L, van Nimwegen M, Hutten SJ, Nguyen KH, Rick J, Eberly S, Faghri F, Auinger P, Scott KM, Wijeyekoon R, Van Deerlin VM, Hernandez DG, Day-Williams AG, Brice A, Alves G, Noyce AJ, Tysnes OB, Evans JR, Breen DP, Estrada K, Wegel CE, Danjou F, Simon DK, Ravina B, Toft M, Heutink P, Bloem BR, Weintraub D, Barker RA, Williams-Gray CH, van de Warrenburg BP, Van Hilten JJ, Scherzer CR, Singleton AB, Nalls MA. Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts. Neurol Genet. 2019;5:e348. doi: 10.1212/NXG.0000000000000348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000348</ArticleId><ArticleId IdType="pmc">PMC6659137</ArticleId><ArticleId IdType="pubmed">31404238</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara JH, Genc B, Cox GA, Bohn MC, Roos RP, Macklis JD, Ulupinar E, Ozdinler PH. Corticospinal motor neurons are susceptible to increased ER stress and display profound degeneration in the absence of UCHL1 function. Cereb Cortex. 2015;25:4259&#x2013;4272. doi: 10.1093/cercor/bhu318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhu318</ArticleId><ArticleId IdType="pmc">PMC4626833</ArticleId><ArticleId IdType="pubmed">25596590</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson P, Wuolikainen A, Thysell E, Chorell E, Stattin P, Wikstrom P, Antti H. Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples. Metabolomics. 2015;11:1667&#x2013;1678. doi: 10.1007/s11306-015-0818-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-015-0818-3</ArticleId><ArticleId IdType="pmc">PMC4605978</ArticleId><ArticleId IdType="pubmed">26491420</ArticleId></ArticleIdList></Reference><Reference><Citation>Konya C, Hatanaka Y, Fujiwara Y, Uchida K, Nagai Y, Wada K, Kabuta T. Parkinson's disease-associated mutations in alpha-synuclein and UCH-L1 inhibit the unconventional secretion of UCH-L1. Neurochem Int. 2011;59:251&#x2013;258. doi: 10.1016/j.neuint.2011.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2011.05.012</ArticleId><ArticleId IdType="pubmed">21693148</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn E, Wu J, Karl J, Liao H, Zolg W, Guild B. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics. 2004;4:1175&#x2013;1186. doi: 10.1002/pmic.200300670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200300670</ArticleId><ArticleId IdType="pubmed">15048997</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Lienden Martijn, Gaspar Paulo, Boot Rolf, Aerts Johannes, van Eijk Marco. Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages. International Journal of Molecular Sciences. 2018;20(1):66. doi: 10.3390/ijms20010066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20010066</ArticleId><ArticleId IdType="pmc">PMC6337583</ArticleId><ArticleId IdType="pubmed">30586924</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Meray RK, Grammatopoulos TN, Fredenburg RA, Cookson MR, Liu Y, Logan T, Lansbury PT., Jr Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease. Proc Natl Acad Sci U S A. 2009;106:4635&#x2013;4640. doi: 10.1073/pnas.0806474106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0806474106</ArticleId><ArticleId IdType="pmc">PMC2651203</ArticleId><ArticleId IdType="pubmed">19261853</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu CH, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, Giovannoni G, Fratta P, Sidle K, Fish M, Orrell R, Howard R, Talbot K, Greensmith L, Kuhle J, Turner MR, Malaspina A. Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis. Neurology. 2015;84:2247&#x2013;2257. doi: 10.1212/WNL.0000000000001642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001642</ArticleId><ArticleId IdType="pmc">PMC4456658</ArticleId><ArticleId IdType="pubmed">25934855</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques AR, Gabriel TL, Aten J, van Roomen CP, Ottenhoff R, Claessen N, Alfonso P, Irun P, Giraldo P, Aerts JM, van Eijk M. Gpnmb is a potential marker for the visceral pathology in Niemann-Pick type C disease. PLoS One. 2016;11:e0147208. doi: 10.1371/journal.pone.0147208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0147208</ArticleId><ArticleId IdType="pmc">PMC4714856</ArticleId><ArticleId IdType="pubmed">26771826</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattsson N, Johansson P, Hansson O, Wallin A, Johansson JO, Andreasson U, Andersen O, Haghighi S, Olsson M, Stridsberg M, Svensson J, Blennow K, Zetterberg H. Converging pathways of chromogranin and amyloid metabolism in the brain. J Alzheimers Dis. 2010;20:1039&#x2013;1049. doi: 10.3233/JAD-2010-091651.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-091651</ArticleId><ArticleId IdType="pubmed">20413871</ArticleId></ArticleIdList></Reference><Reference><Citation>McKeon JE, Sha D, Li L, Chin LS. Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system. Cell Mol Life Sci. 2015;72:1811&#x2013;1824. doi: 10.1007/s00018-014-1781-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-014-1781-2</ArticleId><ArticleId IdType="pmc">PMC4395523</ArticleId><ArticleId IdType="pubmed">25403879</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, Moskites A, Ferrari EJ, Isacson O, Hallett PJ. The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson's disease patients and increases after lysosomal stress. Neurobiol Dis. 2018;120:1&#x2013;11. doi: 10.1016/j.nbd.2018.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.08.013</ArticleId><ArticleId IdType="pmc">PMC6748034</ArticleId><ArticleId IdType="pubmed">30149180</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondello S, Constantinescu R, Zetterberg H, Andreasson U, Holmberg B, Jeromin A. CSF alpha-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders. Parkinsonism Relat Disord. 2014;20:382&#x2013;387. doi: 10.1016/j.parkreldis.2014.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2014.01.011</ArticleId><ArticleId IdType="pubmed">24507721</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagahara Y, Shimazawa M, Tanaka H, Ono Y, Noda Y, Ohuchi K, Tsuruma K, Katsuno M, Sobue G, Hara H. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis. J Neurosci Res. 2015;93:1552&#x2013;1566. doi: 10.1002/jnr.23619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23619</ArticleId><ArticleId IdType="pubmed">26140698</ArticleId></ArticleIdList></Reference><Reference><Citation>Neal ML, Boyle AM, Budge KM, Safadi FF, Richardson JR. The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor. J Neuroinflammation. 2018;15:73. doi: 10.1186/s12974-018-1100-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1100-1</ArticleId><ArticleId IdType="pmc">PMC5842560</ArticleId><ArticleId IdType="pubmed">29519253</ArticleId></ArticleIdList></Reference><Reference><Citation>Offen D, Barhum Y, Melamed E, Embacher N, Schindler C, Ransmayr G. Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant. J Mol Neurosci. 2009;38:85&#x2013;93. doi: 10.1007/s12031-007-9004-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-007-9004-z</ArticleId><ArticleId IdType="pubmed">18651250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta Y, Soucy G, Phaneuf D, Audet JN, Gros-Louis F, Rouleau GA, Blasco H, Corcia P, Andersen PM, Nordin F, Yamashita T, Abe K, Julien JP (2016) Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis. Hum Mol Genet. 10.1093/hmg/ddw304</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5418737</ArticleId><ArticleId IdType="pubmed">28175304</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R, Alves G, Larsen JP, Moller SG. New insight into neurodegeneration: the role of proteomics. Mol Neurobiol. 2014;49:1181&#x2013;1199. doi: 10.1007/s12035-013-8590-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8590-8</ArticleId><ArticleId IdType="pubmed">24323427</ArticleId></ArticleIdList></Reference><Reference><Citation>Park DW, Nam MK, Rhim H. The serine protease HtrA2 cleaves UCH-L1 and inhibits its hydrolase activity: implication in the UCH-L1-mediated cell death. Biochem Biophys Res Commun. 2011;415:24&#x2013;29. doi: 10.1016/j.bbrc.2011.09.148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2011.09.148</ArticleId><ArticleId IdType="pubmed">22001920</ArticleId></ArticleIdList></Reference><Reference><Citation>Percy AJ, Chambers AG, Yang JC, Domanski D, Borchers CH. Comparison of standard- and nano-flow liquid chromatography platforms for MRM-based quantitation of putative plasma biomarker proteins. Anal Bioanal Chem. 2012;404:1089&#x2013;1101. doi: 10.1007/s00216-012-6010-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-012-6010-y</ArticleId><ArticleId IdType="pubmed">22547352</ArticleId></ArticleIdList></Reference><Reference><Citation>Percy Andrew J., Yang Juncong, Chambers Andrew G., Simon Romain, Hardie Darryl B., Borchers Christoph H. Multiplexed MRM with Internal Standards for Cerebrospinal Fluid Candidate Protein Biomarker Quantitation. Journal of Proteome Research. 2014;13(8):3733&#x2013;3747. doi: 10.1021/pr500317d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr500317d</ArticleId><ArticleId IdType="pubmed">24911472</ArticleId></ArticleIdList></Reference><Reference><Citation>Powis RA, Mutsaers CA, Wishart TM, Hunter G, Wirth B, Gillingwater TH. Increased levels of UCHL1 are a compensatory response to disrupted ubiquitin homeostasis in spinal muscular atrophy and do not represent a viable therapeutic target. Neuropathol Appl Neurobiol. 2014;40:873&#x2013;887. doi: 10.1111/nan.12168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12168</ArticleId><ArticleId IdType="pubmed">25041530</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose AA, Annis MG, Dong Z, Pepin F, Hallett M, Park M, Siegel PM. ADAM10 releases a soluble form of the GPNMB/osteoactivin extracellular domain with angiogenic properties. PLoS One. 2010;5:e12093. doi: 10.1371/journal.pone.0012093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0012093</ArticleId><ArticleId IdType="pmc">PMC2919417</ArticleId><ArticleId IdType="pubmed">20711474</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuur M, Ikram MA, van Swieten JC, Isaacs A, Vergeer-Drop JM, Hofman A, Oostra BA, Breteler MM, van Duijn CM. Cathepsin D gene and the risk of Alzheimer's disease: a population-based study and meta-analysis. Neurobiol Aging. 2011;32:1607&#x2013;1614. doi: 10.1016/j.neurobiolaging.2009.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2009.10.011</ArticleId><ArticleId IdType="pubmed">19926167</ArticleId></ArticleIdList></Reference><Reference><Citation>Siebert M, Sidransky E, Westbroek W. Glucocerebrosidase is shaking up the synucleinopathies. Brain. 2014;137:1304&#x2013;1322. doi: 10.1093/brain/awu002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu002</ArticleId><ArticleId IdType="pmc">PMC3999712</ArticleId><ArticleId IdType="pubmed">24531622</ArticleId></ArticleIdList></Reference><Reference><Citation>Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maehlen J, Lehesjoki AE, Tyynela J. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain. 2006;129:1438&#x2013;1445. doi: 10.1093/brain/awl107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl107</ArticleId><ArticleId IdType="pubmed">16670177</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka H, Shimazawa M, Kimura M, Takata M, Tsuruma K, Yamada M, Takahashi H, Hozumi I, Niwa J, Iguchi Y, Nikawa T, Sobue G, Inuzuka T, Hara H. The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis. Sci Rep. 2012;2:573. doi: 10.1038/srep00573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00573</ArticleId><ArticleId IdType="pmc">PMC3417778</ArticleId><ArticleId IdType="pubmed">22891158</ArticleId></ArticleIdList></Reference><Reference><Citation>Trygg J, Wold S. Orthogonal projections to latent structures (O-PLS) J Chemom. 2002;16:119&#x2013;128. doi: 10.1002/cem.695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cem.695</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Sik A, Sakurai T, Nukina N, Takahashi R, Julien JP. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci. 2006;9:108&#x2013;118. doi: 10.1038/nn1603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1603</ArticleId><ArticleId IdType="pubmed">16369483</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis J, Katona I, Muller-Newen G, Sommer C, Necula G, Hendrich C, Ludolph AC, Sperfeld AD. Small-fiber neuropathy in patients with ALS. Neurology. 2011;76:2024&#x2013;2029. doi: 10.1212/WNL.0b013e31821e553a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821e553a</ArticleId><ArticleId IdType="pubmed">21646630</ArticleId></ArticleIdList></Reference><Reference><Citation>Wold S, Esbensen K, Geladi P. Principal component analysis. Chemom Intell Lab Syst. 1987;2:37&#x2013;52. doi: 10.1016/0169-7439(87)80084-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0169-7439(87)80084-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JF, Wuolikainen A, Trupp M, Jonsson P, Marklund SL, Andersen PM, Forsgren L, Ohman A. NMR analysis of the CSF and plasma metabolome of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects. Metabolomics. 2016;12:101. doi: 10.1007/S11306-016-1041-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11306-016-1041-6</ArticleId><ArticleId IdType="pubmed">26883206</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuolikainen Anna, Jonsson P&#xe4;r, Ahnlund Maria, Antti Henrik, Marklund Stefan L., Moritz Thomas, Forsgren Lars, Andersen Peter M., Trupp Miles. Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects. Molecular BioSystems. 2016;12(4):1287&#x2013;1298. doi: 10.1039/C5MB00711A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5MB00711A</ArticleId><ArticleId IdType="pubmed">26883206</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi J, Yang X, Zhao Q, Zheng J, An R, Tian S, Huang H, Hu F, Ning P, Xu Y. Absence of association of the Ala58Val (rs17571) CTSD gene variant with Parkinson's disease or amyotrophic lateral sclerosis in a Han Chinese population. Neurosci Lett. 2018;662:181&#x2013;184. doi: 10.1016/j.neulet.2017.09.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.09.029</ArticleId><ArticleId IdType="pubmed">28917980</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Zhou T, Wang H, Liu T, Ueda K, Zhan R, Zhao L, Tong Y, Tian X, Zhang T, Jin Y, Han X, Li Z, Zhao Y, Guo X, Xiao W, Fan D, Liu G, Chui D. Lipoprotein lipase deficiency leads to alpha-synuclein aggregation and ubiquitin C-terminal hydrolase L1 reduction. Neuroscience. 2015;290:1&#x2013;10. doi: 10.1016/j.neuroscience.2014.12.068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2014.12.068</ArticleId><ArticleId IdType="pubmed">25595992</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Gao L., Wu X., Zhang Y., Zang D. Increased levels of MIP-1&#x3b1;in CSF and serum of ALS. Acta Neurologica Scandinavica. 2015;134(2):94&#x2013;100. doi: 10.1111/ane.12513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12513</ArticleId><ArticleId IdType="pubmed">26427609</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CF, Lin SP, Chiang CP, Wu YH, H'Ng WS, Chang CP, Chen YT, Wu JY. Loss of GPNMB causes autosomal-recessive amyloidosis cutis dyschromica in humans. Am J Hum Genet. 2018;102:219&#x2013;232. doi: 10.1016/j.ajhg.2017.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2017.12.012</ArticleId><ArticleId IdType="pmc">PMC5985536</ArticleId><ArticleId IdType="pubmed">29336782</ArticleId></ArticleIdList></Reference><Reference><Citation>Zigdon H, Savidor A, Levin Y, Meshcheriakova A, Schiffmann R, Futerman AH. Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease. PLoS One. 2015;10:e0120194. doi: 10.1371/journal.pone.0120194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0120194</ArticleId><ArticleId IdType="pmc">PMC4361053</ArticleId><ArticleId IdType="pubmed">25775479</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>